13G Filing: Sio Capital and Catalyst Biosciences Inc. (CBIO)

Page 6 of 6

Page 6 of 6 – SEC Filing

CUSIP No. 14888D208
Page 6 of 6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated:  April 13, 2017
SIO CAPITAL MANAGEMENT, LLC
By:
avigneau_sig.jpg
Name: Albert Vigneau
Title: Chief Financial Officer

Follow Gyre Therapeutics Inc. (NASDAQ:GYRE)

Page 6 of 6